Report me for selling fake medicine? Why are you crying when your illness relapses?

Zhang San's expression became a little more serious.

Someone had advised him this before, but he didn't take it seriously.

But he had to think seriously about what Chen Xuan said.

Chen Xuan didn't say anything else about this.

Zhang San's character is already determined and he cannot be changed with a few words.

……

"A specific drug for pancreatic cancer?"

"How on earth did he do it?"

"Fortunately, we at Novartis don't have this business."

After watching the live broadcast of Antai Pharmaceutical Group's new drug launch conference,

Anna couldn't help but breathe a sigh of relief, but at the same time she was extremely surprised.

Chen Xuan conquered pancreatic cancer and even developed a special medicine that was effective for treating late-stage pancreatic cancer.

This really surprised her.

Once the therapeutic effect is achieved, all related drugs and treatment plans in the world will be put to shame.

Based on Anna's understanding of Chen Xuan,

She thought that since he could announce it, the effect of the medicine would not be too bad.

For example, the specific medicine for liver cancer is like this. It is basically better than what he said. Its efficacy is not compromised at all, and the adverse reactions are not concealed at all.

As long as he said it himself and it was finally verified, it can be trusted.

Therefore, she also believes that once the pancreatic cancer drug is on the market, similar drugs will be beaten and will not be qualified to compete with it at all.

That's why she feels lucky.

The main reason is that Novartis does not have a specific drug to treat pancreatic cancer.

Novartis has also developed drugs for the treatment of pancreatic cancer. For example, an XL drug has entered phase III clinical trials.

However, in the Phase III clinical trial, it was found that the therapeutic effect of this drug was no better than chemotherapy, so Novartis gave up directly.

This also caused a major blow to Novartis' cancer strategy, and its oncology business plummeted and it was no longer competitive.

It was not until Novartis acquired a specific drug for liver cancer that it gained a certain degree of competitiveness in the field of oncology.

But it's also because Novartis has no other oncology business.

Therefore, as long as Novartis' new drug is not related to pancreatic cancer, there will be no competition.

This made Anna start to relax and watch the show.

"And new drugs to treat HIV."

"This medicine can also prevent a variety of infectious diseases."

"Even the adverse reactions alone are better than those of sildenafil. How on earth was it developed?"

After taking a sip of coffee, Anna began to marvel again.

She believes that this drug is worthy of winning the Nobel Prize in Medicine.

In other words, all of Chen Xuan's medical achievements, if taken individually, could make him a Nobel Prize winner.

It is a miracle for other scientists to have only one world-class achievement in their lifetime, but he can have so many at the same time and is qualified to win the Nobel Prize.

Moreover, he is still so young and has infinite possibilities in the future. This makes Anna inexplicably feel that Chen Xuan is extremely terrifying, as if there is nothing he won't do.

It's not like a human being at all.

……

……

"This will wipe out the entirety of Sildenafil."

"I wonder how Pfizer feels? I'm afraid he'll be very depressed."

"If Chen Xuan could have developed it earlier, this scene would have been even more exciting."

Anna suddenly thought of this and couldn't help feeling a little gloating.

You should know that sildenafil is also one of Pfizer's star drugs.

Initially, this drug was used to treat cardiovascular diseases, but after it was launched on the market, they found that its therapeutic effect on cardiovascular diseases was not so obvious.

Instead, due to some adverse reaction, another organ in the body is strengthened.

This led Pfizer to change the use of the drug, and the situation became uncontrollable.

Later, this drug brought Pfizer more than 200 billion in sales. Even after the patent expired, various generic drugs appeared around the world, but the annual sales were not low.